Bliss GVS Pharma Ltd NSE:BLISSGVS:
BLISS GVS PHARMA - APPOINTS RAHUL ADAKMOL AS CEO EFFECTIVE JULY 15, 2026
BLISS GVS PHARMA - NARSIMHA SHIBROOR KAMATH RESIGNS AS CEO EFFECTIVE JULY 14, 2026
Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Bliss GVS Pharma Limited on 6ix
Earlier from Bliss GVS Pharma
- IIFL Asset Management picks up nearly 2% stake in Indo Tech Transformers from promoter
- Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
- Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore
- Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition
- BLISSGVS: Double-digit revenue and profit growth, strong margins, and expansion in global markets
Follow Bliss GVS Pharma into a list and get an email when it puts out news.
Follow Bliss GVS Pharma